To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema (KINGLET)
Abstract
Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
Fields of Study & Subjects
Retinal Diseases and Treatments
Retinal and Macular Surgery
Ocular Diseases and Behçet’s Syndrome
Publication details
- Journal / source
- Vivli
- Publication date
- 12 February 2026
- Language
- EN
- Document type
- Dataset